TerrAscend Corp.

C$0.67As of Sun 8 Nov 2026, 12:00 UTC
TSX:TSNDHealthcare
Country Canada
PE (Fwd) •••
TSR 9Y CAGR (4.91%)
Div yield —
ROE (26.29%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 2.34
PE TTM —
TSR TTM (32.83%)
Mkt cap C$205.6M
ROIC (38.51%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.65
(2.27%)
138.50%
Buy 10|11|12|10|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
19.16%
6.02%
(3.03%)
(2.86%)
Revenue$M
19.91
19.40
20.16
20.54
13.43%
13.79%
12.00%
7.99%
Peers (US$145.5M)
Cap (US$)
PE
146.0M
19.01x
141.7M
20.72x
124.8M
1.968x
Capital
TTM
5Y
10Y
Leveragex
1.263
0.687
0.610
EBIT/Intx
0.638
0.117
0.116
Own earn%
(56.16)
29.61
14.69
Sh yield%
47.17
14.56
15.07
Owners
Insiders/Inst%
0.66
28.58
Short interest%
1.08
SBC / revenue%
4.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
7–12
$1 testx
0.2
Incr. ROIC%
6